Cargando…

Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient

We report a dystrophinopathy patient with an in-frame deletion of DMD exons 45–47, and therefore a genetic diagnosis of Becker muscular dystrophy, who presented with a more severe than expected phenotype. Analysis of the patient DMD mRNA revealed an 82 bp pseudoexon, derived from intron 44, that dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Greer, Kane, Mizzi, Kayla, Rice, Emily, Kuster, Lukas, Barrero, Roberto A, Bellgard, Matthew I, Lynch, Bryan J, Foley, Aileen Reghan, O Rathallaigh, Eoin, Wilton, Steve D, Fletcher, Sue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521967/
https://www.ncbi.nlm.nih.gov/pubmed/26247048
http://dx.doi.org/10.1002/mgg3.144
_version_ 1782383894547398656
author Greer, Kane
Mizzi, Kayla
Rice, Emily
Kuster, Lukas
Barrero, Roberto A
Bellgard, Matthew I
Lynch, Bryan J
Foley, Aileen Reghan
O Rathallaigh, Eoin
Wilton, Steve D
Fletcher, Sue
author_facet Greer, Kane
Mizzi, Kayla
Rice, Emily
Kuster, Lukas
Barrero, Roberto A
Bellgard, Matthew I
Lynch, Bryan J
Foley, Aileen Reghan
O Rathallaigh, Eoin
Wilton, Steve D
Fletcher, Sue
author_sort Greer, Kane
collection PubMed
description We report a dystrophinopathy patient with an in-frame deletion of DMD exons 45–47, and therefore a genetic diagnosis of Becker muscular dystrophy, who presented with a more severe than expected phenotype. Analysis of the patient DMD mRNA revealed an 82 bp pseudoexon, derived from intron 44, that disrupts the reading frame and is expected to yield a nonfunctional dystrophin. Since the sequence of the pseudoexon and canonical splice sites does not differ from the reference sequence, we concluded that the genomic rearrangement promoted recognition of the pseudoexon, causing a severe dystrophic phenotype. We characterized the deletion breakpoints and identified motifs that might influence selection of the pseudoexon. We concluded that the donor splice site was strengthened by juxtaposition of intron 47, and loss of intron 44 silencer elements, normally located downstream of the pseudoexon donor splice site, further enhanced pseudoexon selection and inclusion in the DMD transcript in this patient.
format Online
Article
Text
id pubmed-4521967
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-45219672015-08-05 Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient Greer, Kane Mizzi, Kayla Rice, Emily Kuster, Lukas Barrero, Roberto A Bellgard, Matthew I Lynch, Bryan J Foley, Aileen Reghan O Rathallaigh, Eoin Wilton, Steve D Fletcher, Sue Mol Genet Genomic Med Original Articles We report a dystrophinopathy patient with an in-frame deletion of DMD exons 45–47, and therefore a genetic diagnosis of Becker muscular dystrophy, who presented with a more severe than expected phenotype. Analysis of the patient DMD mRNA revealed an 82 bp pseudoexon, derived from intron 44, that disrupts the reading frame and is expected to yield a nonfunctional dystrophin. Since the sequence of the pseudoexon and canonical splice sites does not differ from the reference sequence, we concluded that the genomic rearrangement promoted recognition of the pseudoexon, causing a severe dystrophic phenotype. We characterized the deletion breakpoints and identified motifs that might influence selection of the pseudoexon. We concluded that the donor splice site was strengthened by juxtaposition of intron 47, and loss of intron 44 silencer elements, normally located downstream of the pseudoexon donor splice site, further enhanced pseudoexon selection and inclusion in the DMD transcript in this patient. John Wiley & Sons, Ltd 2015-07 2015-04-15 /pmc/articles/PMC4521967/ /pubmed/26247048 http://dx.doi.org/10.1002/mgg3.144 Text en © 2015 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Greer, Kane
Mizzi, Kayla
Rice, Emily
Kuster, Lukas
Barrero, Roberto A
Bellgard, Matthew I
Lynch, Bryan J
Foley, Aileen Reghan
O Rathallaigh, Eoin
Wilton, Steve D
Fletcher, Sue
Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient
title Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient
title_full Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient
title_fullStr Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient
title_full_unstemmed Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient
title_short Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient
title_sort pseudoexon activation increases phenotype severity in a becker muscular dystrophy patient
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521967/
https://www.ncbi.nlm.nih.gov/pubmed/26247048
http://dx.doi.org/10.1002/mgg3.144
work_keys_str_mv AT greerkane pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient
AT mizzikayla pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient
AT riceemily pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient
AT kusterlukas pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient
AT barrerorobertoa pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient
AT bellgardmatthewi pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient
AT lynchbryanj pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient
AT foleyaileenreghan pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient
AT orathallaigheoin pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient
AT wiltonsteved pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient
AT fletchersue pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient